Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Potentia completes round of financing to advance POT-4 clinical program in AMD

April 14, 2008

Cationorm launched in France for dry eye symptoms

April 11, 2008

Visual stability seen with pegaptanib maintenance therapy in neovascular AMD

April 9, 2008

Ranibizumab under study in patients with pigment epithelial detachments

April 9, 2008

Reduced retinal thickness seen with VEGF Trap-Eye in neovascular AMD

April 9, 2008

Recent data on bevacizumab in ocular disorders presented

April 9, 2008

Novel antiglaucoma agents disclosed in recent Allergan patent

April 8, 2008

Intravitreal JSM-6427 well tolerated in age-related macular degeneration patients

April 8, 2008

ISTA reports results from clinical trial of once-daily Xibrom for ocular inflammation

April 4, 2008

Recent Merck & Co. patent discloses new remedial options for glaucoma

April 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...